In a bid to make drugs more affordable in India, the government has constituted a committee of joint secretaries, which will ensure enhanced affordability, availability and accessibility of drugs for the citizens. Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya has said that the committee will suggest ways to make pricing policy in favour of poor patients.
The committee will also review the scope of Drugs (Price Control) Order 2013 (DPCO 2013) and suggest ways for strengthening the regulatory provisions of the order. It will also delve into making the existing mechanisms for collection of market based data on prices of medicines more robust and will suggest ways for strengthening the existing pharmaceutical database management system.
Moreover, the panel will also look at procedural improvements and process of re-engineering in NPPA to ensure better and quicker implementation of the government policy and bring greater transparency so as to reduce litigations and review petitions.
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: